NetworkNewsBreaks

WednesdayOct 18, 2017 1:23 pm

NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Attains CE Mark for Smart Glucose Meter on Latest Apple (NASDAQ: AAPL) Devices; Shares Rise

Shares of DarioHealth (NASDAQ: DRIO) are up 40.5% following the company’s news this morning that it has received the CE Mark for its Lightning®-enabled version of the Dario™ Blood Glucose Monitoring System. This ensures that consumers in the UK are able to continue to use the company’s services on the latest Apple (NASDAQ: AAPL) devices. Upon receiving the CE Mark, the company can now offer its proprietary meter with either a 3.5mm headphone jack or a Lightning connector. "We are proud that our organization worked with agility to ensure connectivity to the latest Apple devices. This significant milestone will allow…

Continue Reading

WednesdayOct 18, 2017 1:21 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 18, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: CNET 9.33% – News: 28.com subsidiary releases update for mobile app LPCN 8.89% – News: FDA schedules advisory committee for TLANDO™ on January 10 TROV 8.86% – News: Reports positive preclinical data on PCM-075 with Zytiga® APWC 5.26% – News: Declares cash dividend YIPI 5.00% – News: Becomes primary vendor for enterprise search and discovery for Digital Federal Credit Union HPJ 4.35% – News: Names new independent director FTXP 3.13% – News: Acquires 21%…

Continue Reading

WednesdayOct 18, 2017 11:27 am

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Enters Collaboration Agreement with Phasex Corporation

Pressure BioSciences, Inc. (“PBI”) (OTCQB: PBIO), a leader in the development and sale of innovative solutions for the worldwide life sciences industry, this morning announced a collaboration with Phasex Corporation, one of the world’s most experienced supercritical fluid (“SCF”)-based toll processors. The goal of the collaboration is to combine PBI’s recently patented Ultra Shear Technology with Phasex’s SCF-based processing methods to enable the development of stable, water-soluble nanoemulsions of nutraceuticals, including CBD-enriched plant oil. “Rapidly expanding markets for non-psychoactive extracts of cannabis plant material, for instance, is an example of a potentially high demand application for our combined, synergistic technologies,” Richard…

Continue Reading

WednesdayOct 18, 2017 10:40 am

NetworkNewsBreaks – EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018

EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017, with sales surpassing $250,000. “Our national sales team continues to expand EVIO's service offerings,” William Waldrop, CEO of EVIO, stated in the news release. “After an impressive 2017, in which we exceeded our own internal projections, we are starting the 2018 fiscal year on the right track. We are eagerly waiting for the upcoming accreditation of our new pesticide equipment. As mentioned in our 8K, the…

Continue Reading

WednesdayOct 18, 2017 10:06 am

NetworkNewsBreaks – Greenkraft, Inc. (GKIT) Announces California Clean Air Act Certification for Alternative Fuel Engine

Greenkraft, Inc. (OTCQB: GKIT), a nationally recognized player in the alternative fuel engine and vehicle market, this morning announced that its 8L V8 Gasoline, CNG, and LPG fuel-injected engine received new certification from the California Air Resources Board’s “On-Road New Vehicle and Engine Certification Program.” In order to earn certification under this program, vehicles must demonstrate that exhaust and evaporative emission controls systems are durable and comply with the emission standards for the vehicle’s useful life. Greenkraft’s 8L V8 fuel-injected engine achieved a NOx emission value of less than 0.02 g/bhp-hr, meeting the California Air Resource Board’s optional near-zero NOx…

Continue Reading

WednesdayOct 18, 2017 9:30 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, the expression of GSK3β is reduced by as much as 62 percent. “Based on this and other previously announced compelling data, we are readying IGC-AD1, brand name Hyalolex, in a liquid formulation for commercialization in early 2018,” Ram Mukunda, CEO of IGC, stated in the news release. “We have identified Germany, Canada and certain licensed medical…

Continue Reading

TuesdayOct 17, 2017 12:33 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on October 17, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: NEOT 100.13% – News: Enters merger agreement with Evofem Biosciences, Inc. to create women's health company INSG 9.56% – News: Moves on momentum from recent collaboration deal AMDA 5.60% – News: Receives listing extension from Nasdaq BLSP 4.74% – News: Posts shareholder update DRNE 4.17% – News: Secures contract with U.S. Department of Defense for WASP system MYSZ 3.88% – News: Adds Susan Moses and supermodel Emme to team ASRV 3.85% – News: Posts…

Continue Reading

TuesdayOct 17, 2017 12:29 pm

NetworkNewsBreaks – Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) Shares Surge after Receiving Final FDA Protocol Guidance for TSC Phase 3 Clinical Trial

Shares of Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) are up 35.4% this morning after the company said it has received final protocol guidance from the U.S. Food and Drug Administration (FDA) for a phase 3 clinical trial with trans sodium crocetinate (TSC) in patients newly diagnosed with inoperable glioblastoma multiforme (GBM), a type of brain cancer. The trial will compare survival at two years of patients receiving the company’s lead compound TSC with chemotherapy and radiation (standard of care), with patients receiving the standard of care alone. Diffusion intends to begin the trial under the protocol agreed upon by the FDA…

Continue Reading

TuesdayOct 17, 2017 12:08 pm

NetworkNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary on Pace for Record-Breaking Quarter

PotNetwork Holding, Inc. (OTC: POTN) today announced that its wholly owned subsidiary, Diamond CBD, Inc., achieved combined sales of more than $3.2 million for July and August. This total is equivalent to 60 percent of the company’s revenues for the first six months of the year, leading PotNetwork to forecast another record-breaking quarter. This projection is further strengthened by Diamond CBD’s early reports for September sales, which the company notes “exceeded expectations” in spite of service interruptions stemming from Hurricane Irma. “We continue to be excited by our continued escalating revenues month-after-month,” Maria Gomez, regional vice president of sales for…

Continue Reading

TuesdayOct 17, 2017 11:05 am

NetworkNewsBreaks – RJD Green, Inc. (RJDG) Appoints Bryan Porto to Board of Directors

RJD Green, Inc. (OTC: RJDG), a holding company focused on green environmental services, health care technology and services, and manufacturing/distribution of construction and industrial products, this morning announced changes to its board of directors. In addition to accepting the resignation of Rex Washburn from the position of director due to compelling health issues, the company’s board has accepted the nomination of Bryan Porto as its newest board director. Porto brings more than three decades of senior executive experience to the RJD Green team, having previously served as an officer and board director for companies in both the public and private sectors.…

Continue Reading